Know Cancer

or
forgot password

Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening


N/A
50 Years
75 Years
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening


This pilot project will evaluate two approaches to implementing the use of a simple printed
PSA screening decision-aid (DA) administered in an urban primary care clinic populated with
a significant number of African-Americans. All subjects will complete a survey assessing
their knowledge and attitudes about PSA screening and shared decision making (SDM), and
physicians will also be briefly queried about their perceptions of the SDM process.

After the first three month implementation period we will conduct focus groups with clinic
staff to guide changes and refinements to the use of DA in the clinical setting. Another
three month implementation period will follow using the same methods to assess outcomes.
Finally we will conduct another round of focus groups to assess the overall impact of the
interventions.

Inclusion Criteria


Inclusion criteria:

- Males ages 50-75

- Able to read and speak English

- Provide written informed consent

Exclusion criteria:

- Diagnosis of prostate cancer

- PSA testing within last 12 months

- Previous prostate biopsy

- Voiding problems as reason for clinic visit

- Visit scheduled same day or 'walk-In' patient

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

Provider Satisfaction with Implementation of the Shared Decision Making Process

Outcome Description:

Will be determined through a combination of surveys and responses to questions derived during focus groups.

Outcome Time Frame:

At 3-5 Months

Safety Issue:

No

Principal Investigator

Christopher Warlick, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Masonic Cancer Center, University of Minnesota

Authority:

United States: Institutional Review Board

Study ID:

2011NTLS071

NCT ID:

NCT01484665

Start Date:

December 2011

Completion Date:

June 2012

Related Keywords:

  • Prostate Cancer
  • PSA screening
  • Decision aids
  • Prostatic Neoplasms

Name

Location

Broadway Family Medicine Clinic Minneapolis, Minnesota  55455